Showing results (151-160 of 435) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|July 31, 2020
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelatorsEuy Sung Moon, Filipe Elvas, Gwendolyn Vliegen, et al.
EJNMMI Radiopharmacy and Chemistry|August 26, 2022
Cutting edge rare earth radiometals: prospects for cancer theranosticsAlexander W E Sadler, Leena Hogan, Benjamin Fraser, et al.
EJNMMI Radiopharmacy and Chemistry|June 25, 2020
Imaging using radiolabelled targeted proteins: radioimmunodetection and beyondJavad Garousi, Anna Orlova, Fredrik Y Frejd, et al.
EJNMMI Radiopharmacy and Chemistry|September 8, 2021
Highlight selection of radiochemistry and radiopharmacy developments by editorial boardFrancisco Alves, Inês F Antunes, Emiliano Cazzola, et al.
EJNMMI Radiopharmacy and Chemistry|May 26, 2021
Production of scandium radionuclides for theranostic applications: towards standardization of quality requirementsR Mikolajczak, S Huclier-Markai, C Alliot, et al.
EJNMMI Radiopharmacy and Chemistry|November 13, 2025
Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitutionKarim Obeid, Ekaterina Bezverkhniaia, Vladimir Tolmachev, et al.
EJNMMI Radiopharmacy and Chemistry|October 28, 2025
Automated radiosynthesis of [18F]fluoromannitol for clinical research on a commercially available trasis allinone radiosynthesizerAmy L Vāvere, Allison J Clay, Arijit Ghosh, et al.
EJNMMI Radiopharmacy and Chemistry|September 8, 2025
Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's diseaseDag Sehlin, Ximena Aguilar, Marta Cortés-Canteli, et al.
Pageof 44